Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30019458HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30019459HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30085139HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30023974HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30023975HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30023976HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30023977HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS20042586HPVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS20027367HPVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS20034731HPVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TCGA Plot Options
Drug Information
GeneJAK1
DrugBank IDDB12500
Drug NameFedratinib
Target IDBE0004145
UniProt IDP23458
Regulation Typeinhibitor
PubMed IDs27473820
CitationsRoskoski R Jr: Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases. Pharmacol Res. 2016 Sep;111:784-803. doi: 10.1016/j.phrs.2016.07.038. Epub 2016 Jul 26.
GroupsApproved; Investigational
Direct ClassificationBenzenesulfonamides
SMILESCC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
Pathways
PharmGKBPA166280361
ChEMBLCHEMBL1287853